Tg Therapeutics (TGTX) Non Operating Income (2011 - 2026)
Tg Therapeutics' (TGTX) quarterly Non Operating Income came in at -$14.4 million in Q1 2026, down 357.58% year-on-year from $5.6 million in Q1 2025, and down 167.21% quarter-over-quarter from -$5.4 million in Q4 2025.
Tg Therapeutics (TGTX) Non Operating Income (2011 - 2026) Analysis & Trends
Tg Therapeutics' Non Operating Income history runs 16 years deep, the most recent figure standing at -$14.4 million for Q1 2026.
- On a quarterly basis, Non Operating Income fell 357.58% year-over-year to -$14.4 million in Q1 2026; TTM through Mar 2026 was -$27.2 million, a 50.5% decrease from a year earlier, with the FY2025 full-year figure at -$15.9 million, up 2.45% from the prior year.
- Non Operating Income eased to -$14.4 million in Q1 2026 per TGTX's latest filing, from -$5.4 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$854000.0 in Q3 2023 and bottomed at -$14.4 million in Q1 2026.
- The 5-year median for Non Operating Income is -$2.3 million (2024), against an average of -$3.5 million.
- Across the five-year window, Non Operating Income sank 856.21% in 2024 and surged 57.68% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$932000.0 in 2022, then slumped by 65.34% to -$1.5 million in 2023, then plunged by 191.76% to -$4.5 million in 2024, then fell by 20.13% to -$5.4 million in 2025, then sank by 167.21% to -$14.4 million in 2026.
- Per Business Quant, the three latest TGTX Non Operating Income figures stand at -$14.4 million (Q1 2026), -$5.4 million (Q4 2025), and -$3.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | -14.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.43 Mn |
| Dec 31, 2025 | -5.40 Mn |
| Sep 30, 2025 | -3.46 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -4.50 Mn |
| Sep 30, 2024 | -8.17 Mn |
| Jun 30, 2024 | -2.27 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Sep 30, 2023 | -854,000.00 |
| Jun 30, 2023 | -2.94 Mn |
| Mar 31, 2023 | -2.24 Mn |
| Dec 31, 2022 | -932,000.00 |
| Sep 30, 2022 | -855,000.00 |
| Jun 30, 2022 | -1.57 Mn |
| Mar 31, 2022 | -2.14 Mn |
| Dec 31, 2021 | -391,000.00 |
| Sep 30, 2021 | -509,000.00 |
| Jun 30, 2021 | -1.01 Mn |